A week of NX announcements: finalist in the Swiss Technology Awards, moved up in the rankings of the Top 100 Swiss Start-Ups and featured in The Pathologist
The first week of September 2025 has brought three exciting recognitions highlighting our progress in commercializing spatial single-cell proteomics for precision oncology.
Selected as a finalist in the Swiss Technology Awards
Navignostics was announced as one of three finalists for the Swiss Technology Award 2025. The award recognizes Swiss innovations with the potential for lasting impact. The award is industry-agnostic and looks for the most promising technologies in 3 categories: industry innovation, start-ups and inventors. Jana Fischer (CEO and co-founder) will pitch NX to the jury in October and the winners will be announced at the Open-I conference on the 26th of November.
Featured in The Pathologist
Navignostics was also profiled in The Pathologist, where Stéphane Chevrier (CSO and co-founder) and Bernd Bodenmiller (board member and co-founder) and clinical partner Andreas Wicki discussed findings from the Tumor Profiler study published in Nature Medicine. The study explored how a multiomics approach, including our spatial proteomics test, can inform treatment decisions in late-stage melanoma in 75% of cases and achieved a three-fold increase in progression-free survival in comparison to a matched cohort. In the article, Helen Bristow sought to understand the clinical implications of the study, including how:
- comprehensive profiling can guide treatment when standard options have been exhausted
- important automation is in turning 40,000+ data points into a fast and actional report
- AI will be essential in unlocking the full potential of these datasets.
Climbing the Ranks:
#4 in the Top 20 Swiss Biotech Startups and #32 in the Top 100 Swiss startups
Navignostics also climbed up one place in the Top 20 Swiss Biotech ranking, from #5 in 2024 to #4 in 2025, and two places in the Top 100 Swiss Start-up Awards, from #34 to #32.
The Top100 Swiss Startup Award is Switzerland’s most trusted benchmark for entrepreneurial excellence and innovation leadership. Every year, a panel of 100 leading investors and startup experts chooses the 100 most innovative and promising Swiss startups. Each jury member nominates 10 Swiss startups that are fewer than five years old and show the greatest commercial potential.
